SNHG5 and colorectal carcinoma: Importantly, it remains to be determined whether SNHG5 can regulate the expression or activity of GNB2—either directly or indirectly—to co-drive metastatic phenotypes such as enhanced migration, invasion, survival, and immune evasion in CRC cells.